Interpace Biosciences, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 229.4% | -77.3% | -182.3% |
| FY2022 | 321.1% | -63.7% | -386.7% |
| FY2023 | 62.6% | 9.9% | 4.9% |
| FY2024 | 63.8% | 17.3% | 14.3% |
| FY2025 | 62.3% | 10.5% | 63.5% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 229.4% | -77.3% | -182.3% |
| FY2022 | 321.1% | -63.7% | -386.7% |
| FY2023 | 62.6% | 9.9% | 4.9% |
| FY2024 | 63.8% | 17.3% | 14.3% |
| FY2025 | 62.3% | 10.5% | 63.5% |